12:00 AM
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Defibrotide: Phase I started

Gentium said investigators at Fukushima Medical University began a Japanese Phase I trial to evaluate defibrotide in healthy volunteers. Gentium is providing the compound and technical support to the university. Last month, EMA's CHMP issued a negative opinion recommending against approval...

Read the full 185 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >